Cargando…
Centrally acting anticholinergic drug trihexyphenidyl is highly effective in reducing nightmares associated with post‐traumatic stress disorder
INTRODUCTION: Following a case study on scopolamine butyl bromide, an anticholinergic drug, we studied the effect of a central anticholinergic drug on post‐traumatic stress disorder (PTSD)‐related flashbacks and nightmares. METHODS: We administered trihexyphenidyl (TP) to 34 patients with refractory...
Autores principales: | Sogo, Katsumasa, Sogo, Masanobu, Okawa, Yoshie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213645/ https://www.ncbi.nlm.nih.gov/pubmed/33991066 http://dx.doi.org/10.1002/brb3.2147 |
Ejemplares similares
-
PS256. New drug therapy and the effect mechanism that the central anticholinergic drug Trihexylphenidyl reduces flashback in PTSD. The second report
por: Katsumasa, Sogo
Publicado: (2016) -
Trihexyphenidyl Misuse in Delusional Disorder
por: Mahal, Pankaj, et al.
Publicado: (2018) -
MUNCHAUSEN' SYNDROME AND TRIHEXYPHENIDYL DEPENDENCE
por: Qureshi, N.A., et al.
Publicado: (1993) -
Nightmare Frequency, Nightmare Distress and the Efficiency of Trauma-Focused Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder
por: Levrier, Katia, et al.
Publicado: (2016) -
TRIHEXYPHENIDYL DEPENDENCE—REPORT OF TWO CASES
por: Michael, Albert, et al.
Publicado: (1984)